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Normal human plasma contains the precursor of a  potent proteolytic enzyme of 
broad specifidty, called plasmin or fibrinolysin.  One action of pla~m~n~ measurable in 
the  test tube,  is the inactivation of human complement (C  I)  (1-3). This effect of 
p]~min appears to involve two steps. Plantain activates an enzyme, Cq esterase, from 
its precursor, the first component of complement (Cq)  (4,  5).  Once activated,  Cq 
esterase inactivates the hemolytic properties of the second and fourth components of 
complement, C'2 and C~4 (4). 
Cq, as it exists in human serum, is a macromolecule containing at least three sub- 
components, C'lq, C'lr, and Cqs (6, 7). The precursor of C~I esterase has been identi- 
fied with the Cqs moiety (7), while C'lq and Cqr are required for the "spontaneous" 
generation of Cq esterase from C'ls (7). In the experiments to be described, plasmin 
converted C'ls into C'I esterase in the absence of C'lq and Cqr. The concentration of 
plasmin which was effective was comparable to that which can be generated in vitro 
from normal human plasma. 
The  esterase-inducing  properties of plasmin were demonstrated  in  preparations 
which  had been activated either with streptok~n0:se or chloroform.  Laurell and her 
associates (3)  were unable to confirm  these observations. They suggested that the 
inactivation of complement described  in our earlier studies was due to complement 
fi~tion by a complex formed between a component of the streptokinase preparation 
and specific antibody. In the present study, purified human plasminogen, the precursor 
of plasmin, was activated by urokinase,  an agent in human urine thought to be non- 
antigenic (8, 9). Such urokinase-activated plasmin converted partially purified prep- 
arations of C'ls into C'I esterase,  as demonstrated by the appearance of esterolytic 
activity and the inactivation of C'2 and C~4. The identity of the C'I esterase was sup- 
ported by the observation that it was inactivated by the  C'I esterase inhibitor of 
human serum, but not by soybean trypsin inhibitor. 
These  various  observations  demonstrate  that  the  activation  of  C'ls  may 
take place through a  proteolytic process. In agreement with this,  trypsin was 
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found to generate C'I  esterase  from partially purified C'ls.  Once CPl  esterase 
formed,  however,  its esterolytic properties were diminished by further incuba- 
tion with plasmin or trypsin. The demonstration that  C'ls can be changed to 
C'I  esterase  by two  proteases  raises  the possibility that  the activation of C'I 
esterase during complement fixation is enzymatic in nature. 
Materials 
Partially  purified  human  C'lq,  C'lr,  and  C'Is  were  prepared  by chromatography  upon 
columns of diethylaminoethyl  cellulose (DEAE) in the presence of 0.001 ~ trisodium ethylene- 
diaminetetraacetic acid (Na3HEDTA) as described  previously (7). Pools of these three sub- 
components of C'1 were  dialyzed separately against triethanolamine-buffered saline (TBS)  1 
containing  0.001 ~t Na3HEDTA at I°C for 16 hr, reducing the ionic strength in each to 0.15. 
Aliquots were stored at -- 70°C for periods  up to 2 months or maintained at 4°C for one wk. 
For purposes of expressing the concentrations  of the subcomponents, these dialyzed pools were 
described  as "undiluted." 
Reagents deficient in C'I, C'2, and C'4,  designated R1, R2, and R4 respectively were pre- 
pared  from human serum essentially as described  by Mayer  (10)  with modifications sum- 
marized by Wedgwood  (11). 
Sensitized  sheep erythrocytes (EA) were prepared from sheep blood, collected  monthly in an 
equal volume of Alsever's solution and stored at 4°C. The red ceils were washed,  standardized 
spectrophotometrically, and sensitized  with an equal volume of anti-Forssman rabbit serum, 
as described  previously (10). Following sensitization, the cells were washed twice with equal 
volumes of TBS-gelatin buffer and restandaxdized  to the desired concentration. 
Human serum  was obtained by collecting human blood without an anti-coagulant. The 
blood was allowed  to clot at room temperature, stored overnight at 4°C,  and separated by 
eentrifugation at I°C. Pools from 5 to 20 donors were frozen in aliquots and stored at --70°C. 
C'1 esterase, purified from human serum by the method of Haines and Lepow  (12) and dis- 
solved in TBS, was obtained from Dr. I. H. Lepow. The preparation used contained 52 units 
per ml, as tested upon a substrate of N-acetyl-I,-tyrosine  ethyl ester (ALTEE) by the method 
described  in the present study, one unit being that amount which leads to the release of 0.5 
microequivalent  of acid in 15 rain under the conditions  used (13). 
Partially  purified  pla,vminogen was  prepared  by adaptation of methods of Robbins and 
Sumnmria (14), Cole (15), and Hagan (16) from Cohn fraction III4 of human plasma,  2 using a 
recently published method (17). In different batches,  approximately 10-30% of such "plas- 
minogen" was in the form of plasmin, measured by the capacity to digest casein  without further 
activation. It contained trace amounts of clot-promoting activities which shortened the ab- 
normally long dotting times of plasmas deficient  in Hageman factor  (factor XII), plasma 
thromboplastin antecedent (PTA, factor XI), Christmas factor (factor IX), factor VII, and 
Stuart factor  (factor  X).  No measurable antihemophilic factor  (factor  VIII), proaecelerin 
(factor V), prothrombin (factor  II), C'I esterase,  or C'I subeomponents was  present.  The 
1 The  following  unusual abbreviations are  used  in  this  paper:  ALTEE  (also  ATEE), 
N-acetyl-L-tyrosine ethyl ester; BAEE,  2g-benzoyl-x.-arginine ethyl ester; CTA, Committee 
on Thrombolytie Agents, United States Public Health Service;  EA, sensitized sheep erythro- 
eytes; EI,  human C'I esterase  inhibitor; PTA, plasma thromboplastin antecedent; PTCK, 
L-l-tosylamido-2-phenylethylchloromethyl  ketone; SBTI, soybean trypsin inhibitor; TAME, 
P-toluenesulfonyl-L-arginine  methyl ester; TBS, triethanolamine-buffered  saline; TPCK, L-1- 
tosylamido-2-phenylethylchloromethyl  ketone. 
2 Cohn fraction III4 was furnished by the Cutter Laboratories, Berkeley,  Calif. OSCAR D.  RATNO~':F AND  GEORGE  B.  NA.F~"  339 
plasminogen preparations used in the present experiments, dissolved at concentrations of 4-8 
Remmert and Cohen (18) units per ml of 0.05  M tris(hydroxymethyl)aminomethane  (Tris), 
0.1  M sodium chloride, and 0.02 ~  lysine at pH 9.0, were dialyzed overnight at 4°C against 
approximately 100 volumes of TBS, with or without 0.001  ~  Na3HEDTA.  In  some experi- 
ments,  sufficient  0.15  ~  calcium chloride was added  to provide a  concentration of 0.001  x¢ 
Ca  z+ in the plasminogen solution. More concentrated plasminogen preparations were obtained 
by lyophilization in the presence of the Tris-sodium chloride-lysine buffer, reconstituting the 
residue with an appropriate volume of water and dialyzing the solutions against TBS; no loss 
was incurred by this procedure. 
Purified human urokinase,  3 dissolved in TBS containing 0.001 M NasHEDTA or 0.001 
Ca  z+ at a concentration of 500 "CTA" units per ml, was used to convert plasminogen to plas- 
rain. The preparation of urokinase used contained 175,000 units per mg of nitrogen. The same 
results were obtained with a second preparation  4 containing 275,000 units per nag of nitrogen. 
The concentration of urokinase was one-fourth that which by it,ll hydrolyzed N-acetyl-L- 
tyrosine ethyl ester in the assay used. 
Bovine trypsin,  twice crystallized,  dialyzed salt-free and  lyophili~d, was obtained from 
Worthington Biochemical Corporation,  Freehold, N.J. According to the manufacturer,  the 
preparation  contained  180 esterolytic units per nag. The trypsin was dissolved in TBS. In 
some experiments the TBS contained either 0.001 K Na3HEDTA or 0.001 g  Ca  ~. A second 
preparation of bovine trypsin, described as "TPCK-treated"  (Gallard-Schlesinger Chemicai 
Manufacturing  Corporation,  New York)  to reduce cont~mln~tion with chymotrypsin,  was 
also used. The lyophilized preparation,  said to contain "8300 BAEE units" of trypsin and 
"40 ATEE units" of chymotrypsin per mg was dissolved in TBS containing 0.001  ~  Ca  ~'. 
Alpha  chymotrypsin,  three  times  crystallized  (Worthington  Biochemical  Corporation) 
was dissolved at various concentrations in TBS containing 0.001 ~  Ca  z+. 
Bovine tkrombin ("topical thrombin," Parke Davis & Company, Detroit) was dissolved at 
a concentration of 1000 NIH units per ml of TBS containing 0.001 M Ca  z+. This preparation 
is known to be contaminated with plasminogen, Stuart factor, and proaccelerin, as well as 
other plasma components. 
A suspension of papain  (Worthington Biochemical Corporation), said by the manufacturer 
to contain 12.6 nag of protein per ml and  13.5 units per nag of protein, was diluted suitably 
in TBS containing 0.001 M NaffIEDTA and 0.01 g cysteine, adjusted to pH 7.4. 
L-l-tosylamido-2-pkenylethylchlorometkyl  ketone (PTCK),  B  grade  (Caibiochem,  Los 
Angeles), an inhibitor of cliymotrypsin, was dissolved at a concentration of 0,002  ,~ in Methyl 
Cellosolve. 
Soybean trypsin inkibitov  (SBTI),  three times cryst~lli,.ed  and lyophilized (Worthington 
Biochemical Corporation),  was suspended at suitable  concentrations  in  TBS contn.lning  either 
0.001 M Ca  s+ or 0.001 ~ Na~tIEDTA. 
Human C~1 est~rase inkib~or (El), partially purified from serum by chromatography upon 
Dowex 2 resin and DEAE,  5 was kindly provided by Dr. J. Pensky. It was dissolved at a con- 
centration of 25 units per ml in TBS; 1 unit of EI, in the context of this paper, is the amount 
which neutralizes the esterolytic properties of  10 units  of C~I esterase,  as assayed by the 
method described herein. This unitage does not correspond exactly to that used elsewhere, 
because the assay for C~I esterase was slightly modified from that of Levy and Lepow (13). 
N-acetyl-L-tyrosine etkyl ester (ALTEE), prepared in the laboratories of the Department of 
8 Human urokinase was furnished by Abbott Laboratories, North Chicago, Ill. 
4 Human  urokinase  was provided by Sterling-Winthrop  Research  Institute,  Rensselaer, 
New York. 
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Chemistry, Western Reserve University, was dissolved at a concentration of 1 ~s in 2-meth- 
oxyethanol  (Methyl  Cellosolve,  Eastman  Organic  Chemicals,  Inc.,  Rochester,  N.Y.).  P- 
toluenesulfonyl-L-arginine methyl ester (TAME) (Nutritional Biochemicals Corporation, Cleve- 
land, Ohio) was dissolved at concentration of 0.16 ,s in sodium phosphate buffer,  ionic stregth 
1.07, pH 7.4. 
The buffers used  were triethanolamine-buffered saline  (TBS),  at  pH  7.4,  ionic strength 
0.15 (19), TBS-gelatin buffer, prepared by dissolving gelatin (Knox Gelatine Protein Products, 
Inc., Camden, N.J.) at a concentration of 0.05% in TBS, TBS containing Na3HEDTA, cab 
cium chloride, or magnesium sulfate at suitable concentrations, and sodium phosphate  buffers 
of appropriate pH and ionic strength. 
Salts of ethylenediaminede2raacel~ acid (EDTA) were prepared in the following way. Reagent 
grade Na~H2EDTA was titrated to pH 7.4 at a stock concentration of 0.15 M, giving a solution 
largely in the form of Na3HEDTA.  Na2MgEDTA  (Geigy Chemical Corporation,  Ardsiey, 
N.Y.) was titrated to pH 7.4 at a stock concentration of 0.15 M. 
Methods 
Measurement of Esterolytic Activity. The effect of plasmin upon subcomponents of Cq was 
tested by mLxing various combinations of 0.5 ml each of plasminogen, urokinase, C'lq or C'lr 
or 1.0 ml of C'ls, adjusting the volume to 2.0 ml with TBS. The mixtures, and suitable con- 
trol mixtures, were incubated in disposable glass tubes  (internal  diameter  11  ram)  at  37°C 
for 30 rain, and then transferred to a bath of melting ice. The TBS used to prepare and dilute 
the reagents contained either0.001 u  Ca  ~- or 0.001 M  NaaHEDTA. 
The hydrolytic activity of the various mixtures was measured upon a substrate of ALTEE. 
Immediately after the tubes were placed in the ice bath, 0.375 ml of phosphate buffer (pH 7.4, 
ionic strength 1.07) was pipetted into each tube to inhibit spontaneous activation of C'I ester- 
ase and to increase the buffering capacity of the assay mixture. In succession,  0.125 ml of 1 
ALTEE was added to each tube, which was incubated at 37°C for 15 rain. Just after the addi- 
tion of ALTEE and at the end of the 15 rain period, 1 ml aliquots of the mixtures were added 
to 1 mi of neutralized 38% formaldehyde in the titration cup of a Radiometer model ABU 1 
automatic  burette  (Cophenhagen,  Denmark).  The  titratable  acidity in  each  aliquot  was 
measured by adding sufficient 0.05 M sodium hydroxide with the automatic burette to bring 
the hydrogen ion concentration of the mixture to a predetermined end point, usually pH 7.4. 
The titrations were performed with a  Radiometer model TTT 11  titrator,  controlled by a 
Radiometer model 25 pH meter. 
The effects of trypsin, alpha  chymotrypsin, thrombin, and papain were tested  in the same 
manner,  1 mi of each enzyme, dissolved in TBS containing 0.001  M Ca  ~- or 0.001  x¢ Nas- 
HEDTA, replacing plasminogen and urokinase in the  enzyme-substrate mixture. Alpha chy- 
motrypsin, thrombin, and papain were tested only for their effect upon C'ls, while trypsin was 
incubated with C'lq, C'lr, or Cqs. After alpha chymotrypsin had been incubated with C~ls 
for 30 rain, in the manner described, 0.05 ml of 0.002 xf PTCK was added in an unsuccessful 
attempt to block the action of this enzyme upon ALTEE. The TBS used to dissolve papain 
contained 0.001 M  Na3HEDTA and 0.01 M  cysteine, adjusted to pH 7.4. 
The effect of mixtures of plasmin and subcomponents of C'1 upon TAME was determined 
by essentially the same method.  2 mi of 0.16 M TAME was added to 2.0 ml of the mixture of 
plasminogen, urokinase, and C~1 subcomponents,  and the mixture incubated at 37°C for 60 
rain. Aliquots of I ml were withdrawn before and after the hour of incubation and mixed with 
1 ml formaldehyde solution, and the volume of 0.05 zq sodium hydroxide needed to bring the 
pH of this mixture to 7.4 measured. 
The effect of SBTI upon the development of esterolytlc activity was determined by adding 
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plasmin or trypsin and components d  C'I. By adding the SBTI before or after the enzyme-C'l 
component mixtures were incubated, it was possible to determine whether this inhibitor in- 
flueneed the activation of C~1 esterase, or the effect of the esterase upon ALTEE or TAME. 
The influence of proteases upon the esterolytlc activity of C~1 esterase was assessed  by 
incubating 1.0 ml of C'I esterase (25 units per nd) and either 1.0 ml of trypsin (6/zg per ml) 
or 0.5 ml each of plasminogen (16 units per ml) and urokinase (500 units per ml) for 30 rain 
at 37°C.  The reaction was then stopped by transferring the tubes to an ice water bath and 
adding 0.375 ml of sodium phosphate buffer (pH 7.4, ionic strength  1.07) containing 2.5 mg 
SBTI. Esterolytic activity was then measured upon the addition of 0.125 ml of 1 ~  ALTEE. 
The effect of the serum inhibitor of C~I esterase (EI) upon the enzymatic activity evolved 
by the interaction of plasmin and CIls was determined by adding 0.0125-0.05  ml of a solution 
of EI containing 25 units per ml to a mixture of plasmin and C'ls which had been incubated at 
37°C for 30 rain. This mixture was incubated for an additional 30 rain and then its esterolytic 
activity measured. SBTI, sufficient to provide a concentration during the esterolytic assay of 
1 mg per ml, was added to the plasmin-C'ls mixture in a volume of 0.375 ml sodium phosphate 
buffer (pH 7.4, ionic strength  1.07) just before the addition of EI, to halt further action of 
plasmin. 
Mea,~urement of Hemolytic Ac~ivi~y.--EAC~I, an intermediate complex possessing  the func- 
tional activity of C'I, was measured as described earlier (7) by using the subcomponents of 
C'1 (C'lq, C'Ir, and C~ls). The diluent was TBS-gelatin buffer containing 0.001 ~r Ca2+. The 
activity of the complex EACh1 was quantified by measuring the extent of hemolysis produced 
by a 1/100 dilution of human serum containing 0,016 It Na2MgEDTA. Since this salt prevents 
further action of C~1 by chelating calcium ions, while permitting other components of comple- 
ment to react, its addition provides a way to measure C~1 in unknown preparations. 
C~lq, C'lr, and C~ls were measured by their ability to form the complex EAC~I, as de- 
scribed before (6, 7). In these experiments, a mixture containing 0.5 nfl of a 1/100 dilution of 
each subeomponent was incubated with a button containing 5 X  10  s sensitized erythrocytes 
(EA) for 10 rain at 37°C to form the complex EACh1. The inadiration  of C~4 in solu~m by C~1 
esterase was measured, as described by Haines and Lepow (20), by adding 0.4 ml of R1 to each 
of a series of 12 X  75 mm glass tubes containing 0.2 ml of serial 2-fold dilutions of the sample 
to be tested. These mixtures were incubated for 30 rain at 0°C and a  1/8 dilution of each was 
made. An 0.2 ml aliquot of each dilution was tested for residual Ct4 activity, using 0.1 ml R4, 
0.2 nfl buffer, and  1.0 ml EA (2.5  X  10  s sensitized erythrocytes). TBS-gelatin  buffer,  con- 
taiulng 0.0005 M Mg  s+ and 0.00015 ~s Ca  ~, was used as the diluent in this series of experiments. 
After incubation for 30 rain at 37°C, the extent of hemolysis was estimated by visual compari- 
son with a standard representing 500/0 hemolysis. The end point was taken as that dilution of 
the original test sample which resulted in 50~o hemolysis after 1/8 dilution in the final incuba- 
tion mixture. 
The procedure for estimating the inactivation of C'2 by C~I esteraee was the same as that 
for C~4 inactivation except that all incubations were performed at 37°C and residual C~2 ac- 
tivity was assayed by using 0.05 ml of R2. 
Sucrose  Density  Gradient  Ultracentrifugation.--I.u these experiments,  approximate linear 
gradients of 5-20%  (w/v) sucrose in TBS buffer containing 0.001  ~' Na3HEDTA were pre- 
pared as described previouly (6). Mixtures containing 1.5 ml of undiluted Ctls and 1.5 ml of 
either trypsin (6/~g per ml) or buffer were incubated for 30 rain at 37°C, and 0.56 ml of SBTI 
(6.7 mg per ml) was added. 0.1 ml of each preparation and 0.1 ml of bovine serum albumin (10 
mg per ml)  (Armour Laboratories, Chicago) were layered upon separate sucrose gradients. 
After centrifugation, the C~ls fractions were tested for Ctls activity while the optical density 
of the albumin marker fractions was read at 210 m/~, using a Zeiss PMQH spoctrophotometer. 342  CONVERSION  OF ctls TO C'I ESTERASE 
RESULTS 
I.  The Effect of Plasmin upon the Hydrolysis of ALTEE by Subcomponents of 
C'l.--In agreement with previous studies, a  mixture  of C'lq,  Cqr,  and  C'ls 
acquired the capacity to hydrolyze ALTEE, while each of the subcomponents 
alone or any combination of two lacked this property (Table I, Nos. 1-8). 
TABLE I 
Esterolytic Properties of Plasminogen,  Urokinase, and the First Component of Complement (C'1) 
1.  Buffer 
2.  C'lq 
3.  C'lr 
4.  C'ls 
5.  C'lq +  C'Ir 
6.  C'lq +  Cqs 
7.  C'lr +  C'ls 
8.  C'lq +  C'lr +  C~ls 
9.  Plasminogen 
10.  Urokinase 
Mixture* 
Esterase  activity 
ALTEE 
g~ of acid ll- 
' bera~d in 15 rain 
0 
0 
0 
0 
0 
0 
0.2 
7.6 
0.1 
0.7 
TAME 
a//q of acid l/- 
b~rated in 1 
0 
1.6 
1.1 
1.7 
1.7 
0 
0.3 
3.9 
2.9 
0 
11.  Plasminogen +  urokinase 
12.  Plasminogen +  C'ls 
13.  Urokinase +  C'Is 
14.  Plasminogen +  urokinase +  C'lq 
15.  Plasminogen +  urokinase +  C'lr 
16.  Plasminogen +  urokinase +  C'lq +  C'lr 
17.  Plasminogen +  urokinase +  C'ls 
18.  Plasminogen +  urokinase +  C'ls +  SBTI (added be- 
fore generation of esterase activity) 
19.  Plasminogen +  urokinase -k C'ls +  SBTI (added after 
generation of esterase activity) 
20.  C'lq -4- C'lr +  C'ls -k SBTI (added before generation 
of esterase activity) 
21.  C'lq +  C'lr +  C'ls +  SBTI (added after generation 
of esterase activity) 
0.4 
0.4 
0.1 
0 
0 
0 
2.7 
0.2 
2.5 
7.2 
8.7 
16.5 
3.2 
0 
18.5 
14.5 
13.3 
16.7 
0.3 
0.1 
1.7 
3.4 
* Suitable combinations of 0.5 ml each of plasminogen  (4 units per ml),  urokinase  (500 
units per ml),  "undiluted"  C'lq and  Cqr,  1.0 ml of "undiluted" C'ls, and  sufficient TBS 
to bring the volume to 2.0 ml were incubated  at 37°(2 for 30 rain.  Esterolytic activity for 
ALTEE was determined by adding 0.375  ml of sodium phosphate  (pH  7.4,  ionic strength 
1.07) and 0.125 ml of 1 u  ALTEE, and incubating this mixture for 15 rain. Esterolytic activ- 
ity for TAME was measured by adding 2 ml of 0.16 ~  TAME to the 2.0 ml of the original 
mixture and incubating for 60 rain at 37°C. Additions of 0.1 ml SBTI (25 mg per ml) were 
made before or after the first period of incubation. In this experiment, all reagents were in 
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The  preparations  of  plasminogen  tested  did  not  of  themselves  hydrolyze 
ALTEE (Table I, No. 9). They invariably contained some plasmin, as deter- 
mined by tests for caseinolytic activity, but plasmin does not digest ALTEE 
measurably  (17).  Urokinase,  in  the  concentrations  used,  lacked  significant 
hydrolytic activity against ALTEE (Table I, No. 10).  Similarly, a  mixture of 
plasminogen and urokinase was  without  esterolytic activity directed against 
this substrate (Table I, No. 11). 
When  plasminogen  and  urokinase  were  incubated  with  a  preparation  of 
Cqs, significant esterolytic activity against ALTEE evolved. No such activity 
appeared when plasminogen and urokinase were incubated with either C'lq or 
C'lr or a combination of these two subcomponents (Table I, Nos. 12-17). The 
TABLE II 
E gut of Plasmin ana Trypsin upon C'I EsUrase 
Mixture*  Esterase activity 
Plasminogen -{- urokinase 
Trypsin 
C'I esterase 
C'I esterase -t- plasminogen +  urokinase 
C'I esterase +  trypsin 
of acid lib~atcd ln 15 mln 
0.1 
0.1 
13.1 
10.4 
4.6 
* Combinations of 0.5 ml plasminogen (16 units per ml), 0.5 ml urokinase (500 units per 
ml), 1.0 ml purified C'1 esterase (25 units per nil), and sufficient  TBS to bring the volume to 
2.0 ml were incubated at 37°C for 30 rain. Esterolytic activity was measured by adding 
0.375 ml of sodium phosphate buffer (pH 7.4, ionic strength 1.07) containing 2.5 nag SBTI 
and 0.125 ml 1 g ALTEE, and incubating this mixture for 15 min. 
esterolytic  activity  whiCh  could  be  measured  in  mixtures  of  plasminogen, 
urokinase, and C'ls was always less than that which developed in mixtures of 
Cqq,  C'lr,  and  C'ls.  Increasing  the  concentration of  plasminogen  fourfold 
increased the titer of esterase activity only from 2.6 to 3.9 microequivaients of 
acid liberated in 15 mln. This suggested that plasmin not only activated  Cqs 
but also inhibited Cq  esterase. Indeed, a  mixture of plasminogen, urokinases 
and purified C'I  esterase had less esterolytic activity than C'I  esterase alone 
(Table H).  Thus,  the degree of esterolytic activity measured in mixtures of 
plasminogen,  urokinase,  and  Cqs  may have been limited by this  inhibitory 
property of plasmln. 
In  summary,  a  mixture  of plasmlnogen,  urokinase,  and  C'ls  evolved the 
capacity to digest ALTEE, a property not shared by the mixture of plasminogen 
and urokinase or  C'ls  alone.  These data  are compatible with  the view that 
urokinase-activated plasmin can convert C'ls to C'1 esterase in the absence of 
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H.  The Effect of Plasmin upon the Hydrolysis of TAME by Subcomponents of 
C'l.--In  contrast  to  ALTEE,  TAME  is  a  relatively poor  substrate  of C'I 
esterase, but an excellent  substrate of plasmin  (5).  Thus,  a  mixture  of C11q, 
C'lr,  and Cqs evolved slight  hydrolytic activity towards TAME, while each 
subcomponent alone  or any combination of two had a  lesser  effect upon this 
substrate (Table I, Nos. 1-8). As would be expected, the preparation of plas- 
minogen  tested had  some esterolytic activity that  was greatly enhanced  by 
incubation with urokinase  (Table I, Nos.  9--11). Under the conditions of the 
assay, no further activity against TAME evolved upon incubation of urokinase 
and plasminogen  with C'ls, or, indeed,  with any subcomponent of C'I  (Table 
I, Nos. 12-17). 
These experiments sharply separate the esterolytic properties of plasmin and 
C'I esterase,  in conformity with our expectations. 
III.  The Effect of Inhibitors  upon the Esterolytic Properties of Plasmin and 
Crl  Esterase.--SBTI  is  an  effective inhibitor  of plasmin  (21),  but  does not 
inhibit  the hydrolysis of ALTEE by C'I  esterase.  In the present study,  the 
addition  of SBTI  to a  mixture  of plasminogen  and  urokinase  inhibited  the 
evolution of esterolytic activity against both ALTEE  and TAME  (Table I, 
Nos.  17,  18). After  plasminogen,  urokinase,  and  C'ls  had  been  incubated 
together for 30 rain,  the addition of SBTI blocked hydrolysis of TAME,  but 
was without effect upon hydrolysis of ALTEE  (Table I,  No.  19). It did not 
prevent the evolution of hydrolytic activity against ALTEE in a  mixture  of 
Cqq,  C'lr,  and  Cqs  although  it  may have  had  a  minimal  effect (Table I, 
Nos. 20, 21). 
Serum  possesses  inhibitory  activity  directed  against  C'I  esterase.  EI,  a 
purified  fraction of serum, rich in this inhibitory activity, interfered with the 
digestion of ALTEE by the agent which developed in mixtures of plasminogen, 
uroldnase, and C'ls (Table III). The degree of inhibition was essentially that 
predicted from the action of EI upon purified  C'I esterase.  This observation is 
in agreement with the view that the enzyme derived from C'ls upon treatment 
with plasmin is C'I esterase. 
IV.  The Effect of Plasmin upon the Hemolytic Activity of the Subcomponents 
of C'l.--The  experiments thus far described imply that plasmin changes C'ls 
to C'I esterase. These experiments do not exclude the possibility that the prep- 
arations  of plasminogen  and  urokinase  might  have  been contaminated  with 
Cq  or its  subcomponents.  Earlier,  such  contaminants  could not  be demon- 
strated in plasminogen  prepared by the technique used in the present study 
(17). This possibility was reexamined because of its crucial  importance in the 
interpretation of the current experiments. 
The hemolytic activity of Cqq, Cqr, and C'ls was measured by determining 
the  extent  of  the  formation  of  the  intermediate  complex  EACq.  In  these 
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incubating the subcomponents  of Cq with EA, i.e. sensitized erythrocytes, for 
10 mln at 37°C and measuring  the extent of hemolysis after the addition of 
human serum containing Nag  MgEDTA (7). As shown previously,  a mixture 
of C'lq, C'lr, and C'ls was effective in forming the complex EAC'I, while the 
complex  did not form when combinations  of any two  subcomponents  were 
tested (Table IV). 
The  effect  of urokinase  and plasminogen  upon formation of the  complex 
EAC'I was studied in a similar  way. As shown in Table IV, preparations of 
TABLE III 
E.~evt of Serum Inhibitor  of C'1 Esteroze (EI) upon Esterolyt~  Properties of Mixtures of 
Plasminogen, Urokinase, and C'Is 
EI added to test mixture* 
o 
o.31 
0.62 
1.25 
Esterase activity* 
Inhibitory activity$ 
Experimental  I 
3.7 
2.5 
1.1 
0.3 
~  acid liberated in 15 rain 
o 
1.2 
2.6 
3.4 
Predicted 
0 
1.6 
3.1 
3.7 
* Mixtures of 0.5 ml plasminogen (16 units per ml), 0.5 ml urokinase (500 units per nil), 
and 1.0 ml C'ls were incubated at 37°C for 30 rain, and then transferred to an ice water bath. 
A volume of 0.375  ml sodium phosphate buffer (pH 7.4, ionic strength  1.07)  containing 2.5 
mg SBTI, and 0 to 0.05 ml of a solution of EI (25 units per ml) were added to each tube and 
the mixtures reincubated  at 37°C for 30 rain. The esterolytic activity of the mixtures was 
then determined by incubating each with 0.125  ml 1 ~  ALTEE for 15 rain. 
Experimentally determined inhibitory activity was obtained by subtracting the number of 
microequivalents of acid liberated in 15 rain in the presence of EI from that liberated in its 
absence. The predated inhibitory activity wasderived from the inhibitory titer of the prepa- 
ration of EI, as tested against purified C'I esterase by the same esterolytic method. 
urokinase or plasminogen, alone or in combination, were not capable of forming 
this  intermediate complex.  In  addition, mixtures  containing urokinase  and 
plasminogen and combinations  of any two subcomponents  of C'I were unable 
to form the complex EAC'I. The addition of urokinase  and plasminogen  to 
mixtures containing the three subcomponents  of C'I did not appreciably affect 
the extent of formation of this complex, while SBTI may have decreased the 
yield of EAC'I slightly when added before or after the preincubation of sub- 
components of C'I with EA. 
These experiments  show that neither uroklnase  nor the plasminogen prepa- 
rations used contained significant  amounts of C'lq,  C'lr,  or  C'ls.  Nor did 
urokinase-activated plasmin function as a subcomponent of C'I in the formation 
of EAC'I. These experiments  indicate,  therefore,  that the conversion of C'ls 346  CONVERSION  OF CqS TO  CI1  ESTERASE 
to  C'I  esterase  by  plasmin  cannot  be  attributed  to  its  contamination  with 
Cqq and C'lr. 
V.  The  Inaztivation  of  Cr2  and  C4  by  Plasmin-Activated  C1  Estera3e.-- 
Previous  experiments  by  Haines  and  Lepow  (20)  have  demonstrated  that 
solutions  of  Cr2  and  C'4  are  inactivated  by  C'I  esterase.  If  plasmin  truly 
TABLE IV 
Effect of Plasmin on Formation of ltze Complex EAC'I 
Cqq*  C'lr*  C'ls*  Urokinase*  Plasminogen*  SBTI  ODit 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+§ 
+11 
0.862 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.016 
0.005 
0.000 
0.000 
0.000 
0. 787 
0. 707 
o. 757 
0.007 
* These preparations were such that the concentration of each was a  1/100 dilution of the 
same reagent used for studying the generation of C'I esterase. The total volume in all cases 
was 1.5  ml. 
~t Optical density at 541 m/z, corrected  for EA control. 
§ 0.1  ml SBTI, containing 25 rag/m1 added  to reaction mixture before formation of the 
complex EACq. 
II 0.1 ml SBTI containing 25 mg/ml added to reaction mixture after formation of the com- 
plex EACq. 
changed Cqs to Cq  esterase,  one would expect that the product of the  inter- 
action of plasminogen, urokinase, and C'ls would inactivate C~2 and  Ct4.  To 
investigate this, aliquots of the mixtures used to test the generation of esterolytic 
activity were incubated at 37°C for 30 rain and maintained in an ice bath until 
used. 
When a mixture of C'lq,  Cqr,  and C'Is or a mixture of plasminogen,  uro- 
kinase,  and  C'ls  was  incubated  with  R1,  a  significant  amount  of  C'4  was 
inactivated,  as  shown  in  Table  V.  For  example,  the mixture  containing un- OSCAR  D.  RATNOFI~ AND  GEORGE  B.  IqAFF  347 
diluted C'lq, C'lr, and C'ls inactivated C'4 in the R1 preparation. Only when 
the mixture of C'lq,  C'lr, and C'ls was diluted 64-fold before mixing with 
R1 was its capacity to inactivate C'4 decreased to the point at which as much 
as 50 % hemolysis was noted when the R1 preparation was assayed with R4. 
In contrast, mixtures of plasminogen and urokinase  alone or plasminogen and 
C'ls alone did not inactivate significant  amounts of C'4. In all cases, samples 
capable of inactivating C'4 contained esterolytic activity, as measured by the 
hydrolysis of ALTEE. Mixtures incapable of inactivating C'4 did not hydrolyze 
this substrate. In a companion series of experiments,  using the same reaction 
mixtures,  C'2  was  also  inactivated only by those  mixtures  possessing  the 
capacity to hydrolyze ALTEE. 
These experiments  demonstrated that  C'ls,  incubated in the  presence  of 
either a mixture of C'lq and C'lr or urokinase  and plasminogen acquired the 
TABLE V 
Inactivation of C'4 by C'I Esterase  Generated  from Mixtures Containing  Plasminogen, Urokinase, 
C'lq  C'ir 
"4- 
C'ls 
+ 
+ 
+ 
Uroklnase 
+ 
+ 
+ 
and  Yls 
Plasminogen 
+ 
+ 
+ 
Hemolytic tlter, 
dilution of 
test sample* 
1/2 
1/8 
1/32 
* Dilution of test sample required for 50%  hemolysis. 
ability to inactivate C'4 and C'2 in the R1 fraction of serum. This inhibitory 
property paralleled  the  esterolytic activity of these mixtures.  Since the in- 
activation of C'4 and C'2 in solution is a function of C'1 esterase  (20), these 
data support the view that plasmin  can convert Ctls to C'1  esterase  in the 
absence of C'lq and C'lr. 
VI.  The Effect of Trypsin upon the Esterolytic Properties of Ctl.--The activa- 
tion of C'ls by plasmin suggested that other proteases might effect this trans- 
formation. To test this, crystalline trypsin was incubated with C'lq, C'lr, or 
C'ls for 30 rain at 37°C and the reaction was then halted by the addition of 
soybean  trypsin  inhibitor  (Table  VI).  Under  these  conditions,  even  more 
esterolytic activity evolved  in mixtures of trypsin and C'ls than from the 
interaction of C'lq, C'lr, and C'ls. The reaction proceeded optimally when the 
concentration of trypsin was  3  #g per  ml, less esterolytic activity evolving 
under these circumstances  at higher  or lesser concentrations  of the enzyme. 
Presumably, excessive trypsin inhibited either the formation of C'I esterase or 
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evolved when the C'ls was diluted serially (Table VI). Moreover, when trypsin 
was incubated for 30 man with purified C'I esterase, significant loss of esterolytic 
activity  occurred  (Table  H).  Thus  trypsin,  like  plasmin,  appeared  to  inhibit 
C'I  esterase,  as well as to bring about its activation. 
The evolution of C'I esterase did not take place if SBTI was added to trypsin 
before its incubation with C'ls  (Table  VII). Activation was slowed by incuba- 
tion  of  trypsin  with  C'ls  at  0°C,  but  even  at  this  temperature,  significant 
esterolytic  activity  developed  within  as  brief  a  time  as  15  sec  (Table  VIII). 
TABLE VI 
The Esterolytic Properties of Trypsin  and the First Component of Complement 
Buffer 
Cqq 
C'lr 
C'ls 
Mixture*  Esterase activity 
I~4 ~  acld libera~'.d i~ 15 rain 
0 
0 
0 
0 
C'lq +  C'lr +  C'ls 
Trypsin 
Trypsin +  C'lq 
Trypsin +  C'lr 
Trypsin +  C'ls 
Trypsin +  C'ls (diluted 1/2) 
Trypsin +  C'ls (diluted 1/4) 
4.1 
0 
0.5 
1.5 
6.8 
2.4 
0.7 
* Suitable combinations of 1.0 ml trypsin  (6.25/~g  per ml), 0.5 ml C'lq, 0.5 ml C'Ir, and 
1.0 ml C'ls, and TBS were incubated in a volume of 2 mL All reagents had been dissolved in 
or dialyzed against TBS containing 0.001  xt trisodium EDTA. After 30 rain at 37°C, 0.375 
ml sodium phosphate buffer (pH 7.4, ionic strength  1.07) containing 25 nag SBTI and 0.125 
ml 1 M ALTEE were added, and the amount of acid liberated during incubation at 37°C for 
15 rain was measured by the method described. 
TABLE VII 
The Effect of Soybean Trypsin Inhibitor on the Activation of C'ls by Trypsin 
Mixture*  Esterase activity 
ttEq o~ acid liberated  in 
15 mln 
SBTI -{- trypsin +  C'ls incubated 30 rain  0.5 
Trypsin -}- C'ls incubated 30 rain, then SBTI added  8.9 
* 1.90 ml C'ls and 0.10 ml trypsin (62 #g per ml) were incubated at 37°C for 30  rain. Be- 
fore or after the period of incubation, 0.10  ml of SBTI (25 mg per nil) was added to the mix- 
ture. Esterase activity was then determined after the addition of 0.375 ml sodium phosphate 
buffer (pH 7.4, ionic strength 1.07) and 0.125 ml 1 u  ALTEE. The trypsin, C'ls, and SBTI 
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That the enzyme derived from the interaction of trypsin and C'ls was in fact 
C'1  esterase  was  supported  by  its  quantitative  inhibition  by purified  C'I 
esterase inhibitor (Table IX). 
VII.  The Effect of Trypsin upon the Hemolytic Activity of the Subcomponents 
of C'I.--As  the preceding  data  show,  trypsin seems to convert  Cqs  to  Cq 
TABLE VIII 
The E~ect of Temperature  on the Et~olution of Esterase Acridly in Mixtures of Trypsin and C'ls 
Time of incubation 
10 
30 
6O 
180 
3OO 
Esterase activity* 
O*C  I  37°C 
ttF-q of add Hbtrate,  d in 15 r,  ff, 
1.8 
2.4 
3.3 
4.7 
5.8 
2.3 
3.5 
4.5 
4.9 
5.2 
* Mixtures of 6 ml trypsin (6/~g/ml) and 6 m] C'ls were incubated at 0°C or 37°C. At the 
intervals noted, 1.9 ml aliquots were transferred to tubes containing 0.1 ml SBTI (25 nag per 
ml) and 0.375  ml sodium phosphate buffer (pH  7.4, ionic strength  1.07),  and  the  esterase 
activity measured  at 37°C upon the addition of 0.125  ml 1 M ALTEE. The trypsin,  C'ls, 
and SBTI were dissolved in TBS containing 0.001  ~  trisodium EDTA. 
TABLE IX 
Effect of Serum Inhibitor of C'1 Esterase (El) upon Esterolytir, Properties of Mixtures of Trypsin 
and C'  ls 
EI added to test mixture* 
0 
0.31 
0.62 
1.25 
Esterase activity* 
Inhibitory activity~ 
Experimeutal 
7.0 
5.3 
3.9 
1.5 
of acid Igbsrated in 15 roln 
0 
1.7 
3.1 
5.5 
Predicted 
0 
1.6 
3.1 
6.3 
*  Mixtures of  1.0  ml trypsin  (6/~g  per  ml) and 1.0  ml C'ls  were  incubated  at  37°C for  30 
rain and then transferred  to an ice water bath.  A  volume of 0.375  ml sodium phosphate 
buffer  (pH  7.4,  ionic  strength  1.07)  cont~inlng  2.5  nag  SBTI  and  0  to  0.05  ml  of  a  solution  of  EI 
(25  units  per  ml) were  added to  each  tube and the  mixtures  reincubated  at  37°C for  30  mln. 
The esterolytic  activity  of  the  mixtures  was then determined by  incubating  each  with 0.125 
ml I  u ALTEE  for  15  rain. 
Experimentally  determined inhibitory  activity  was obtained  by subtracting  the  number 
of  microequivalents  of  acid  liberated  in  15  rain  in  the  presence  of  EI  from  that  liberated  in  its 
absence.  The pred/cted  inhibitory  activity  was  derived  from the  inhibitory  titer  of  the  prepa- 
ration  of  EI, as  tested  against  purified  C'I esterase  by the same esterolytic  method. 350  CONVERSION  OF  cPlS  TO  cPl  ESTERASE 
esterase. The question arose whether it would substitute for C'lq and C'lr in 
the formation of the complex EAC'I. As shown in Table X, trypsin alone, or 
in combination with any two subcomponents  of C'I, was incapable of forming 
the complex EAC'I. When 0.5 ml aliquots  of Cqq, Cqr, and Cqs, each at a 
1/100 dilution, were incubated with EA for 10 rain in the presence of 0.03/zg 
of trypsin, formation of the complex EACq  was reduced  by approximately 
80 %. However,  when SBTI was added to the reaction mixture before the 10 
min incubation period, formation of the complex EAC'I was only reduced  by 
TABLE  X 
Effect  of Trypsin  on  Formation of the Complex EAC'I 
Cqq,  C~lr,  Cqs,  Trypsin,*  $BTI,  OD ~/ 
0.5 m]  0.5 ml  0.5 mi  0.5 ml  0.1 m] 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
n 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
m 
m 
m 
b 
m 
+§ 
+lI 
0.940 
0.020 
0.025 
0.035 
0.010 
0.012 
0.020 
0.015 
0.170 
0.690 
O. 150 
* Final trypsin concentration of 0.03 #g per ml. 
Optical density at 541 n~, corrected for EA control. 
§ 0.1 ml of SBTI containing 2.5 mg per ml added to reaction mixture before formation of 
the complex EAC'I. 
II 0.1 ml of SBTI containing 2.5 mg per ml added to reaction mixture after  formation of 
the complex EACq. 
approximately 25 %. The addition of SBTI after 10 rain at 37°C was without 
effect, i.e., formation of the complex EAC'I was again reduced by about 80%. 
These experiments  demonstrate that although CPls could be  converted to 
C'I esterase by trypsin, the hemolytic activity of C'I was markedly reduced by 
this enzyme.  Among  other possibilities,  this reduction of hemolytic activity 
may have been due to changes induced in C'lq, Cqr, or Cqs, other than the 
formation of Cq esterase,  which may have occurred during tryptic digestion. 
This possibility  was investigated by preincubating each subcomponent  of C'I 
with trypsin for 10 rain at 37°C. Tryptic activity was inhibited by the addition 
of SBTI to the reaction mixture before or after the preincubation period. Each 
subcomponent  was  then assayed for hemolytic activity by determining the 
extent of formation of the complex EAC'I when incubated in the presence of 
EA and the rema/ning two subcomponents  of C'I. OSCAR  D.  RATNOF1  ~  AND  G~EORG~- B.  NA.F~'  351 
When 0.05/zg of trypsin was preincubated with C'lq, the hemolytic activity 
of  this  subcomponent  of  C'I  was  markedly  reduced,  while  the  hemolytic 
activity of C'lr and C'ls was only moderately decreased (Table XI). Addi- 
tional experiments revealed that the effect of trypsin was dependent upon its 
concentration, since 5.0 gg inactivated more than 90 % of the hemolytic activity 
of either C'lq, C'lr, or C'ls. But trypsin preincubated for 10 rain at 37°C with 
a  500-fold  excess  of SBTI still inhibited the hemolytic activity of C'lq and, 
to a lesser extent, that of C'lr and C'ls (Table XI). These observations raised 
the possibility that SBTI itself inhibited complementary activity, a suggestion 
which will be examined in subsequent paragraphs. 
TABLE  XI 
E.l~e~t of Trypsin on the Hemolytic Actidty of C'lq, C'lr, and C'ls 
C'lq  C'lr  C'ls  Trypsin  SBTI  OD* 
+ 
+ 
+ 
q 
+~ 
+ 
+ 
+§ 
+ 
+ 
-4- 
+ 
+ 
+ 
+~ 
+ 
+ 
+§ 
+ 
+ 
+ 
+ 
+ 
+ 
+~ 
+ 
+ 
+§ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0.900 
0.002 
0.010 
0.011 
0.300 
0.708 
0.769 
0.390 
0.800 
0.839 
* Optical density at 541 mbt, corrected  for EA control. 
:~ Preincubation of either C'lq, C'lr, or C'ls with trypsin (0.05/*g per ml) before  the addi- 
tion of SBTI (0.025 mg per ml). 
§ Preincubation of either C'lq, C'lr, or C'ls with trypsin (0.05 ttg per ml) after the addi- 
tion of SBTI (0.025 mg per ml). 
These experiments with trypsin were compromised by the possibility that 
the preparation used was contaminated with chymotrypsin, which would not 
have been inhibited by SBTI, even though the trypsin preparation used did not 
measurably digest ALTEE. But trypsin treated to reduce contamination with 
chymotrypsin decreased the hemolytic activity of C'lq, C'lr, and C'ls in the 
same  way.  Possible  quantitative  differences in  tryptic  activity among  the 
trypsin  preparations  tested  were  not  investigated.  Notably,  the  hemolytic 
activity of C'lq was partially inhibited by incubation with chymotrypsin-poor 
trypsin which had first been incubated with SBTI, while the hemolytic activity 
of C'lr and C'ls was only slightly depressed. 
These experiments make it unlikely that the loss of hemolytic C'I activity, 
observed when C'lq,  C'lr, or C'ls were incubated with trypsin, was due to 
contamination by chymotrypsin. Furthermore, the inhibitory effect of chymo- 352  CONVERSION  O:F ctls TO ctl ESTERASE 
trypsin-poor trypsin preincubated  with  SBTI was  unexplained.  Since  SBTI 
completely inhibited the conversion of C'ls to C'I esterase by trypsin, it seemed 
unlikely that  the  decrease in  hemolytic activity could be related to  tryptic 
activity which  was  not inhibited by SBTI.  These experiments could be  ex- 
plained were SBTI capable of inhibiting  one or more of the subcomponents 
of C'I. 
To test this hypothesis, SBTI was incubated for 10 rain at 37°C with either 
C'lq, C'lr, or C~ls, and the hemolytic activity of each subcomponent was then 
measured  as  described above.  The  hemolytic activity of  C'lq  was  partially 
inhibited while the decrease in C'lr and C'ls activity was less marked (Table 
TABLE Xll 
Effect of SBTI on the Hemolytic Activity o/C'lq, C'lr, and C'ls 
C'lq  C'lr  C'ls  SBTI  OD 
+ 
+ 
+ 
+* 
+ 
+ 
+~ 
+ 
+ 
+§ 
+ 
+ 
+ 
+ 
+ 
+ 
+* 
+ 
+ 
+* 
+ 
+ 
+§ 
+ 
+ 
+ 
+ 
+ 
+ 
+* 
+ 
+ 
+t 
+ 
+ 
+§ 
+ 
+ 
+ 
+ 
+ 
+ 
0.900 
0.010 
0.013 
0.020 
0.500 
0.770 
0.752 
O. 720 
0.828 
0.860 
0.890 
O. 875 
0.878 
* Preincubafion of either C'lq, C'lr, or C'ls with SBTI  (5.0 mg/ml). 
Preincubafion of either Cqq,  CIlr, or C'ls with SBTI  (0.5  mg/ml). 
§ Preincubsfion of either C'lq,  C'lr,  or C'ls in the absence of SBTL 
XII). The inhibitory effect of SBTI appeared to be directed primarily toward 
C~lq,  but  its  presence  during  the  assay  of  each  subcomponent  made  this 
uncertain.  The available data suggest,  however, that the apparent  inhibition 
observed when SBTI was  preincubated with C'lr and C'ls may be due to the 
interaction of CPlq and SBTI during the formation of the complex EAC'I. 
VIII.  The Inactivation of C'2 and Ct4 in Solution by C'1 Esterase  Generated 
from C'ls  and  Trypsin.--The  preceding experiments imply that  trypsin, like 
plasmin,  could convert C'ls  to C'I  esterase in the absence of C'lq and  Cqr. 
Were this  the  case,  trypsin-activated C'I  esterase should inactivate C'2  and 
C'4, as in the case of plasmin-activated C'ls. To investigate this, 0.2 ml aliquots 
of mixtures prepared for examinlug the effect of trypsin upon the esterolytic 
properties of C'I were used. Tryptic activity was terminated by the addition of 
SBTI, and the mixtures were maintained in an ice bath until used. OSCAR  D.  RATNO~'~'  AND  GEORGE  B.  NAF~"  353 
The  results  from these  experiments  are  shown  in  Table  XIII.  Mixtures 
containing C'ls and trypsin inactivated C'4,  while those  containing C'ls or 
trypsin alone lacked this property. The capacity to inactivate C'4 paralleled 
esterolytic activity, as measured by the hydrolysis of ALTEE. A companion 
series  of  experiments  demonstrated  that  mixtures  containing  trypsin  and 
C'ls inactivated C'2 in solution, while C'ls or trypsin alone did not inactivate 
this component of complement. 
These  experiments,  therefore,  show that C'ls incubated in the presence of 
trypsin acquired  the capacity to inactivate C'4 and C'2 in the R1 fraction of 
serum. Since  the ability to inactivate these two components of complement was 
associated with the capacity to hydrolyze  ALTEE, these data provide additional 
evidence that trypsin can convert Ctls to C'1 esterase  in the absence of the 
other subcomponents  of C'1. 
TABLE XIII 
Inactivation of C'4 by C'1 Esterase Generated from Mixtures Containing Trypsin and C'ls 
C'ls 
+ 
+ 
Trypsin 
+ 
+ 
TBS 
+ 
+ 
+ 
Hemolytic titer, 
dilution of 
test sample* 
i/2 
1/2 
1/32 
1/2 
* Dilution of test sample required for 50% hemolysis. 
IX.  Ultracentrifugal  Studies on C'ls Activated to C'1 Esterase  by Trypsin.-- 
One possible mechanism for the conversion of C'ls to C'I esterase by trypsin 
was provided by the hypothesis that the activation of C'ls was  related to 
cleavage of a peptide fragment from C'ls by trypsin. The cleavage of a peptide 
fragment during the activation of C'ls might be associated  with a change in 
the sedimentation rate of this protein.  The sedimentation behavior of C'ls, 
incubated in the presence and absence of trypsin, was therefore investigated. 
No  such  change  was  observed  upon sucrose  gradient ultracentrifugation of 
C'I esterase obtained by incubating C'ls with trypsin. 
These experiments,  therefore,  suggest  that the  conversion  of C'ls  to  C'I 
esterase by trypsin does not appreciably alter the size or shape of C'ls. Previous 
experiments  (6, 12) have shown that C'I esterase (activated by C'lq and C'lr) 
and Cqs both had a sedimentation coefficient of about 4S, and that the activa- 
tion of C'I  to C'I esterase  was not accompanied  by release of trichloracetic 
acid-soluble  nitrogen or by electrophoretic  changes  (5). Thus, the conversion 
of C'ls to C'I esterase by trypsin may be similar to the activation of C'ls to 
C'I esterase by the interaction of the three subcomponents  of C'I. 
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C'ls and 1.0 ml of chymotrypsin, at concentrations of 1.25 to  10 #g per ml, 
for 30 min at 37°C did not result in esterolytic activity, measured upon a sub- 
strate of ALTEE, beyond that which could be attributed to the chymotrypsin 
alone. Nor did incubation of 1.0 ml of C'ls with 1.0 ml of thrombin, at concen- 
trations ranging from 31 to 500 NIH. units per ml, or with 1.0 ml of papain, at 
concentrations of 0.08-1.25  mg per ml, induce esterolytic activity. 
DISCUSSION 
The first component of complement, C'I, behaves as if it were the precursor 
of a specific hydrolytic enzyme, C'I esterase (22-25). Partially purified prepa- 
rations of C'I lose Cq activity, as measured in certain hemolytic systems, and 
gain esterolytic properties, as tested upon synthetic substrates, when the ionic 
strength is lowered from 0.30 to 0.15  (5, 22). This "spontaneous" formation of 
C'I  esterase  takes  place  only when  three  separable  subcomponents  of  Cq 
(C'lq,  Cqr,  and C'ls)  are present (7).  In serum, these three subcomponents 
appear to be loosely bound together in the form of a macromolecule (6). Estero- 
lytic activity will not evolve even at low ionic strengths in solutions of any of 
the three subcomponents alone, but only when all three are incubated together. 
In this reaction, Cqq and C'lr behave as if they were in some way responsible 
for the activation of an esterase derived from C'ls (7). 
The formation of C'I esterase from preparations of C'I can also be brought 
about by exposure to antigen-antibody aggregates (23). How antigen-antibody 
aggregates bring about the generation of C'I esterase is not understood. The 
experiments  presently described  point  to  one  possible  mechanism,  that  the 
activation of C'I esterase is through a proteolytic process.  This view has been 
proposed  by Taylor and  Fudenberg  (26),  who reported  that epsilon amino- 
caproic acid inhibited the formation of C'I  esterase by sensitized red blood 
cells.  That proteases can convert the first component of complement to  Ctl 
esterase  had  been  suggested  by the  observation  that  this  process  could be 
brought about by plasmin. Incubation of human serum at 37°C with strepto- 
kinase, an activator of plasminogen, resulted in the inactivation of complement 
(1). The decrease in complementary activity appeared to be due to inactivation 
of the first, second, and fourth components of complement, C'I, C~2, and C'4. 
Bovine plasmin, activated by chloroform, had little effect upon whole serum, 
but readily inactivated C'I and C'4 in a euglobulin fraction of serum, R2 (1). 
Further experiments seemed to indicate that the inactivation of components 
of complement occurred at least in part as the result of a sequence of reactions. 
C'2 and C'4 were inactivated by streptokinase or bovine plasmin only in the 
presence  of calcium ions and onIy if C'I  was present  (27).  The sequence  of 
events appeared to be the conversion of C'I to an esterase by plasmin, and then 
the inactivation of C'2 and C'4 by C'I esterase. 
Recently, Laurel/  and  her  associates  (3)  challenged  the  assumption  that OSCAR  D.  RATNOFF  AND  GEORGE  B.  NAFF  355 
plasmin converts  C'I  into  C'I  esterase.  They were  unable  to  demonstrate 
significant  inactivation of complement  by a  highly purified  preparation  of 
streptokinase, Kabikinase (AB KABI, Stockholm, Sweden), or that treatment 
of serum with urokinase  or human plasmin would decrease the titer of C'2 or 
C'4. If the serum was first diluted, both of these components were inactivated 
by human plasmin,  but inactivation occurred  in the absence  of C'I.  These 
experiments  were interpreted to mean that plasmin did not convert C'1 into 
C'1 esterase, but was capable of direct proteolytic destruction of C'2 and C'4. 
The effect of Varidase, the streptokinase preparation used in our earlier studies, 
was thought to be due to complement  fixation by a  complex between com- 
ponents of the streptokinase preparation and specific antibodies in the serums 
tested.  Since  Kabikinase  did  not  decrease  complementary activity,  these 
specific antibodies  were presumably not directed towards streptokinase itself. 
The present studies did not touch upon the question whether complement 
fixation may have explained our earlier results. Rather they demonstrated that 
partially purified preparations of plasmin might have converted C'ls into C'1 
esterase.  The preparations of C'ls tested were only partially purified, but the 
formation of C'1 esterase took place in the absence of C'lq and C'lr, making it 
nnlikely that  complement  fixation  was  responsible.  Moreover,  the  effect  of 
plasmin  was  blocked  by soybean trypsin inhibitor,  a  potent  antagonist of 
plasmin. The agent which evolved when C'ls was incubated with plasmin was 
presumably C'1  esterase,  since  it  hydrolyzed ALTEE, inactivated C'2  and 
C'4,  and was  quantitatively inhibited by purified  esterase  inhibitor derived 
from human serum, while it was not blocked by soybean trypsin inhibitor.  In 
these experiments,  urokinase  was used to activate plasminogen.  This agent, 
derived from human urine,  is believed to be nonantigenic (8, 9). In any case, 
the activation of C'ls was also accomplished  in the absence of urokinase  by 
that fraction of the purified plasmlnogen preparation which was already in the 
form of plasmin. 
These experiments do not bear upon Laurell's (3) interpretation of the effect 
of Varidase upon complement.  Nonetheless,  we have been unable to confirm 
the supposed inertness  of Kabikinase towards complement.  This agent, incu- 
bated with human serum at a concentration of 500 units per ml, reduced the 
titer of complement in human serum from 32.3 to 4.5 CPI-I~0 units per ml, while 
the same amount of Varidase brought the titer to 8.8 units.  6 The reasons for 
the discrepancies between our experiments  and those of Laurell and her asso- 
ciates are not clear. In their experiments, they assessed the degree of available 
plasmin-like activity by applying the material to be tested to heated fibrin plates. 
Areas of fibrinolysis were measured after a period of 18 hr. This technique has 
the inherent drawback that plasrninogen, which may not have been activated 
at the start of the assay, might have changed into plasmin during the incubation 
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period.  Moreover,  plasminogen  is  readily adsorbed  onto  fibrin,  and  in  this 
condition appears to be activated more readily by streptokinase than it is in 
unclotted plasma (28,  29). Thus the fibrin plate assay may have made it seem 
as if more fibrinolytic activity was available to act upon complement than was 
actually the case. Perhaps the differences between Laurell's findings and ours 
might be explained by an overestimation of the amount of plasmin-like activity 
in her experiments. 
Our studies are in agreement with the view that plasmin  can convert the 
first component of complement into C'I  esterase.  Since the  concentration of 
plasmin used was comparable to that which can generate in human serum, it 
is possible that, given the proper setting, plasmin may activate Cq in the body. 
Although  human  serum  contains potent inhibitors  against  plasmin,  perhaps 
local concentrations of the active enzyme may be of physiological significance. 
The observation that Cqs was changed to Ctl esterase by plasmin led to an 
examination of the effect of other proteolytic enzymes. Among those tested, 
only trypsin had the capacity to induce the formation of C'I  esterase, but in 
the test tube it was more effective than either plasmin or a mixture of C'lq and 
C~lr in the absence of calcium ions. That the enzyme evolved was C'I esterase 
was confirmed by demonstrating its inhibition by a purified preparation of its 
specific  inhibitor  EI.  Moreover,  the  C'I  esterase  which  evolved  appeared 
capable of inactivating C~2 and C'4.  Suitable experiments demonstrated that 
the property of activating Ctl esterase resided in the trypsin molecule itself and 
not in a  contaminant of the preparation. Whatever the alteration induced in 
C'ls  by trypsin,  it  could not  be  detected by a  change  in  its  sedimentation 
characteristics, as determined by sucrose gradient ultracentrifugation. 
The effects of plasmin and trypsin were not limited to the activation of C'I 
esterase.  Evidence was  obtained that  both of these enzymes diminished  the 
esterolytic properties of C~I  esterase itself. Thus both Cqs and  C'I  esterase 
appeared to serve as substrates for these enzymes. 
The various experiments described lead directly to the possibility that the 
activation of C'I esterase from C'ls is brought about by the proteolytic action 
of Cqq, Cqr, or a combination of these subcomponents of C'I. In the present 
study,  evidence  is  reported  that  soybean  trypsin  inhibitor  may  block  the 
hemolytic properties of C'lq. In other experiments, not yet published/  TAME 
and phenylmethylsulfonylfluoride, which inhibit the action of some proteases, 
appear to block the action of Cqr upon C'ls. Perhaps, then, CJlr, in its active 
form, is a protease which is able to convert C~ls, a zymogen, into C~I esterase, 
a  second protease. Such a  sequence is reminiscent of the "waterfall" or "cas- 
cade" hypothesis which attempts to explain the steps that lead to the formation 
of a clot as a series of reactions in each of which an enzyme forms which cata- 
lyzes the next step. 
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SUMMARY 
The formation of C'I esterase from Cq, the first component of complement, 
may be brought about by the action of plasmin or trypsin upon Cqs,  a  sub- 
component of C'I. These enzymes also decrease the esterolytic activity of C'I 
esterase.  The  formation of  Cq  esterase  was demonstrated  by measuring  the 
appearance of an agent or agents with esterolytic properties and the capacity 
to inactivate C'2 and C'4, attributes of C'I esterase. The activity of the agent 
which evolved was blocked by serum inhibitor of C~I esterase. The implications 
of these observations, that  the  formation of Cq  esterase during  complement 
fixation is  mediated  by proteolytic processes,  are  under  study.  The  possible 
inhibition  of  Cqq  by  soybean  trypsin  inhibitor  is  in  agreement  with  this 
hypothesis. 
This study could not have been completed without the expert technical a~istance of Miss 
Saundra Gourley, Mrs. Edna Stone, and Mr. Donald Blue. 
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